| Specialty Retail Industry | Consumer Discretionary Sector | Michael C. Withrow CEO | OTCQB Exchange | 68551T103 CUSIP |
| CA Country | 19,534 Employees | - Last Dividend | 19 Mar 2020 Last Split | - IPO Date |
AREV Life Sciences Global Corp. stands as a beacon of innovation in the realm of life science research and discovery in Canada. The company embarks on the early stages of its mission to unravel the complexities of natural compounds, concentrating its efforts on the extraction of these compounds for various applications, including consumption and topical application. Having evolved from its former identity as AREV NanoTec Brands Inc., the company embraced its new title in August 2021 to better reflect its broadened horizon and dedication to life sciences. Situated in Coquitlam, Canada, AREV Life Sciences Global Corp. opens doors to a future where technology and nature converge, epitomized by its Medicine Merchant technology platform. This platform signifies the company's stride towards integrating technology with natural sciences, enhancing the way we approach clinical nutrition and the utilization of natural compounds in medicine.